Malleolar fracture in pregnancy and lactation-associated osteoporosis: a case report and literature review

Abstract

Objective

The incidence of fractures in pregnancy and lactation-associated osteoporosis (PLO) is very low. Some fracture cases of PLO are associated with vertebral compression fractures, while malleolar fractures in patients with PLO are rarely reported before.

Case report

A 31-year-old Han Chinese patient presented with a malleolar fracture 3 months after delivery, while she was still breastfeeding. Temporary closed reduction and plaster external fixation were performed in the emergency room. Then the patient was admitted to the orthopedic trauma ward for surgery and diagnosed as PLO by dual-energy X-ray absorptiometry (DEXA). After preoperative evaluation, the patient underwent open reduction and internal fixation. With the diagnosis of PLO, the patient was treated with weaning, bisphosphonate, and supplementation of calcium carbonate and vitamin D. During the 12-month follow-up period, the results of DEXA and laboratory examination improved gradually, and the internal fixation was removed 12 months after surgery.

Conclusion

Orthopedic doctors should not ignore the possibility of PLO to avoid misdiagnosis of perinatal women with fractures. Improvement of functional recovery of fractures can be achieved with accurate diagnosis and individual treatment.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

Abbreviations

PLO:

Pregnancy and lactation-associated osteoporosis

BMD:

Bone mineral density

DEXA:

Dual-energy X-ray absorptiometry

References

  1. 1.

    Kanis JA, Cooper C, Rizzoli R et al (2020) Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 31(1):209

    CAS  Article  Google Scholar 

  2. 2.

    Gehlen M, Lazarescu AD, Hinz C, Boncu B, Schmidt N, Pfeifer M, Schwarz-Eywill M, Pollähne W, Minne HW (2017) Pregnancy and lactation-associated osteoporosis. Z Rheumatol 76(3):274–278

    CAS  Article  Google Scholar 

  3. 3.

    Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I (2017) Pregnancy-associated transient osteoporosis of the hip: results of a case-control study. Arch Osteoporos 12(1):11

    Article  Google Scholar 

  4. 4.

    Ferrari S, Bianchi ML, Eisman JA et al (2012) Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23(12):2735–2748

    CAS  Article  Google Scholar 

  5. 5.

    Kuroda T, Nagai T, Ishikawa K, Inagaki K (2019) Clinical features and diagnosis of lumbar fractures caused by pregnancy- and lactation-associated osteoporosis. Clin Calcium 29(1):46–50

    PubMed  Google Scholar 

  6. 6.

    Ozturk G, Akpinar P, Karamanlioglu AD, Ozkan FU, Aktas I (2018) Pregnancy-related osteoporotic vertebral compression fractures in two patients treated with low-molecular-weight heparin during pregnancy: case reports. Gynecol Endocrinol 34(5):378–380

    CAS  Article  Google Scholar 

  7. 7.

    Yun KY, Han SE, Kim SC, Joo JK, Lee KS (2017) Pregnancy-related osteoporosis and spinal fractures. Obstet Gynecol Sci 60(1):133–137

    Article  Google Scholar 

  8. 8.

    Nordin BE, Roper A (1955) Post-pregnancy osteoporosis; a syndrome? Lancet 268(6861):431–434

    CAS  Article  Google Scholar 

  9. 9.

    Yang B, Kong L, Hao D (2020) Challenges in the management of pregnancy and lactation associated osteoporosis: literature review and retrospective study. Curr Stem Cell Res Ther

  10. 10.

    Hellmeyer LHPZV (2004) Osteoporose in der Schwangerschaft. Geburtshilfe Frauenheilkd 64:38–45

    Article  Google Scholar 

  11. 11.

    Cohen A, Kamanda-Kosseh M, Dempster DW, Zhou H, Müller R, Goff E, Colon I, Bucovsky M, Stubby J, Nickolas TL, Stein EM, Recker RR, Lappe JM, Shane E (2019) Women with pregnancy and lactation-associated osteoporosis (PLO) have low bone remodeling rates at the tissue level [J]. J Bone Miner Res 34(9):1552–1561

    CAS  Article  Google Scholar 

  12. 12.

    Cerit ET, Cerit M (2020) A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration. Bone Rep 13:100706

    Article  Google Scholar 

  13. 13.

    Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int 29(1):135–142

    CAS  Article  Google Scholar 

  14. 14.

    Kovacs CS, Ralston SH (2015) Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26(9):2223–2241

    CAS  Article  Google Scholar 

  15. 15.

    Kovacs CS (2014) Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 94(4):1143–1218

    CAS  Article  Google Scholar 

  16. 16.

    Kovacs CS (2016) Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 96(2):449–547

    CAS  Article  Google Scholar 

  17. 17.

    Winter EM, Appelman-Dijkstra NM (2017) Parathyroid hormone-related protein-induced hypercalcemia of pregnancy successfully reversed by a dopamine agonist. J Clin Endocrinol Metab 102(12):4417–4420

    Article  Google Scholar 

  18. 18.

    Ardawi MS, Nasrat HA, BA’Aqueel HS (1997) Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 137(4):402–409

    CAS  Article  Google Scholar 

  19. 19.

    Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18(6):832–872

    CAS  PubMed  Google Scholar 

  20. 20.

    Peris P, Guanabens N, Monegal A et al (2002) Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 20(5):697–700

    CAS  PubMed  Google Scholar 

  21. 21.

    Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39(4):487–490

    CAS  Article  Google Scholar 

  22. 22.

    Butscheidt S, Delsmann A, Rolvien T, Barvencik F, al-Bughaili M, Mundlos S, Schinke T, Amling M, Kornak U, Oheim R (2018) Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int 29(7):1643–1651

    CAS  Article  Google Scholar 

  23. 23.

    Collet C, Ostertag A, Ricquebourg M, Delecourt M, Tueur G, Isidor B, Guillot P, Schaefer E, Javier RM, Funck-Brentano T, Orcel P, Laplanche JL, Cohen-Solal M (2018) Primary osteoporosis in young adults: genetic basis and identification of novel variants in causal genes. JBMR Plus 2(1):12–21

    Article  Google Scholar 

  24. 24.

    Winter EM, Ireland A, Butterfield NC, Haffner-Luntzer M, Horcajada MN, Veldhuis-Vlug AG, Oei L, Colaianni G, Bonnet N (2020) Pregnancy and lactation, a challenge for the skeleton. Endocr Connect 9(6):R143–R157

    CAS  Article  Google Scholar 

  25. 25.

    O'Sullivan SM, Grey AB, Singh R et al (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17(7):1008–1012

    CAS  Article  Google Scholar 

  26. 26.

    Hassen-Zrour S, Korbaa W, Bejia I et al (2010) Maternal and fetal outcome after long-term bisphosphonate exposure before conception. Osteoporos Int 21(4):709–710

    CAS  Article  Google Scholar 

  27. 27.

    Jia P, Wang R, Yuan J, Chen H, Bao L, Feng F, Tang H (2020) A case of pregnancy and lactation-associated osteoporosis and a review of the literature. Arch Osteoporos 15(1):94

    Article  Google Scholar 

  28. 28.

    Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, Zhao DC, Wang O, Jiang Y, Xing XP, Xia WB, Li M (2018) Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol 37(11):3141–3150

    Article  Google Scholar 

  29. 29.

    Gaudio A, Fiore CE (2016) Successful neridronate therapy in pregnancy-associated osteoporosis. Clin Cases Miner Bone Metab 13(3):241–243

    PubMed  Google Scholar 

  30. 30.

    Cohen A (2010) Should bisphosphonates be used in premenopausal women? Maturitas 66(1):3–4

    Article  Google Scholar 

  31. 31.

    Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, Rhee Y (2012) Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 30(5):596–601

    CAS  Article  Google Scholar 

  32. 32.

    Coskun BI, Sarpel T, Guzel R (2014) Short-term treatment experience with teriparatide in pregnancy- and lactation-associated osteoporosis. J Obstet Gynaecol 34(8):736

    Article  Google Scholar 

  33. 33.

    Quattrocchi E, Kourlas H (2004) Teriparatide: a review. Clin Ther 26(6):841–854

    CAS  Article  Google Scholar 

  34. 34.

    Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y (2018) Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol (Oxf) 88(5):652–658

    CAS  Article  Google Scholar 

  35. 35.

    Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H (2017) Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol 56(6):863–866

    Article  Google Scholar 

  36. 36.

    Gilsenan A, Midkiff K, Harris D, Kellier-Steele N, McSorley D, Andrews EB (2020) Teriparatide did not increase adult osteosarcoma incidence in a 15-year us postmarketing surveillance study. J Bone Miner Res

  37. 37.

    Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11(5):449–454

    CAS  Article  Google Scholar 

  38. 38.

    Carter TH, Duckworth AD, White TO (2019) Medial malleolar fractures: current treatment concepts. Bone Joint J 101-B(5):512–521

    CAS  Article  Google Scholar 

Download references

Availability of data and materials

All the data supporting our findings are contained within the manuscript.

Author information

Affiliations

Authors

Contributions

XDB and BJW joined the surgery, GW and GQX were involved in information collection of the patient, XDB and GQX reviewed the literature and contributed to manuscript drafting, and GQX and BJW were responsible for the revision of the manuscript. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Baojun Wang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Informed written consent was obtained from the patient for publication of this report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bai, X., Wang, G., Xu, G. et al. Malleolar fracture in pregnancy and lactation-associated osteoporosis: a case report and literature review. Arch Osteoporos 16, 36 (2021). https://doi.org/10.1007/s11657-021-00908-7

Download citation

Keywords

  • Malleolar fracture
  • Pregnancy and lactation-associated osteoporosis (PLO)
  • Dual-energy X-ray absorptiometry (DEXA)
  • Bone mineral density (BMD)